Hannes De Wachter, M.Sc.
Head of Business Development
About MindSpeaker
Technology for expression.Designed around people.
We bring communication software, voice technology and non-invasive brain-computer interface research together to expand access to AAC.
Our mission
Make communication
more accessible.
When speaking or using familiar access methods becomes difficult, having another way to express a message matters.
MindSpeaker’s work combines AI, communication software and non-invasive BCI technology. The focus is practical: helping people explore access methods that fit their abilities and everyday needs.
Researching personalised access
Built in Belgium.
Developed through collaboration.
Based in Herent, MindSpeaker brings together expertise in brain-computer interfaces, software, product development and communication support. Our research roots include the work of Prof. Marc Van Hulle at KU Leuven.
We welcome AAC dealers, speech therapists and research organisations interested in exploring our early MindClick platform. Proposed research examines control signals, electrode configurations, usability and customisation needs. Participant testing requires an agreed research framework and the applicable regulatory, ethics and consent arrangements. Early kits are not offered for routine patient care or onward patient supply.
MindClick provides a trained control input. MindSpeaker helps the user construct and speak the message. Eye navigation is an option—not the defining feature of the BCI approach.
People & expertise
Meet the team.
Prof. Marc Van Hulle
Expert in Computational Neuroscience and Brain-Computer Interfaces, KU Leuven
Arno Libert, PhD
Head of Product Development
Prof. Miet De Letter, Ph.D.
Expert in Neurolinguistics and Clinical Neurosciences, Ghent University
Stijn Vansant
ex Associate Partner IBM Lifesciences
Luc Buntinx
Serial Tech Entrepreneur Ambassador for Independent Living
Prof. Bart de Strooper M.D., PhD
Global Leader in Alzheimer’s Research and Director of the UK Dementia Research Institute
Prof. Maria Grazia Spillantini, PhD
Professor of Molecular Neurology University of Cambridge
Prof. Gil Livingstone, M.D., PhD
Clinical psychiatrist specialising in dementia at the University College London
Dr. Tjasa Mlinaric
Expert in Neuroengineering and Cognitive Monitoring
Prem Aravindan
Chief Technology Officer
Karolina Miklasz
Regulatory Compliance
Juan Gomez
Product Development
Beatrice Marconi
Clinical Trials
Elena Sillis
Customer Success
Individual suitability. Personalised access.
Help turn possibilities into practical access.
Explore a research partnership, attend a prototype demonstration or ask about the development programme.
Development & quality
Building the evidence.
Updating the documentation.
We have established a quality management system to support product development. Our technical documentation and release records are being updated to reflect hardware and software changes. Clinical evaluation and the conformity work for the proposed medical use remain in progress.
A quality management system is not, by itself, confirmation that a product is CE-marked or available for routine patient use.